IL209723A0 - Tetrahydrocinnolines as 11 beta hsd1 inhibitors for diabetes - Google Patents
Tetrahydrocinnolines as 11 beta hsd1 inhibitors for diabetesInfo
- Publication number
- IL209723A0 IL209723A0 IL209723A IL20972310A IL209723A0 IL 209723 A0 IL209723 A0 IL 209723A0 IL 209723 A IL209723 A IL 209723A IL 20972310 A IL20972310 A IL 20972310A IL 209723 A0 IL209723 A0 IL 209723A0
- Authority
- IL
- Israel
- Prior art keywords
- tetrahydrocinnolines
- diabetes
- hsd1 inhibitors
- beta hsd1
- beta
- Prior art date
Links
- WXRSSOIHEAVYLL-UHFFFAOYSA-N 1,2,3,4-tetrahydrocinnoline Chemical class C1=CC=C2NNCCC2=C1 WXRSSOIHEAVYLL-UHFFFAOYSA-N 0.000 title 1
- 101100451537 Caenorhabditis elegans hsd-1 gene Proteins 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/28—Cinnolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08160446 | 2008-07-15 | ||
PCT/EP2009/058470 WO2010006940A1 (en) | 2008-07-15 | 2009-07-06 | Tetrahydrocinnolines as 11 beta hsd1 inhibitors for diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
IL209723A0 true IL209723A0 (en) | 2011-02-28 |
Family
ID=41050326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL209723A IL209723A0 (en) | 2008-07-15 | 2010-12-02 | Tetrahydrocinnolines as 11 beta hsd1 inhibitors for diabetes |
Country Status (17)
Country | Link |
---|---|
US (1) | US8501940B2 (es) |
EP (1) | EP2313375A1 (es) |
JP (1) | JP5575762B2 (es) |
KR (1) | KR20110036579A (es) |
CN (1) | CN102089287B (es) |
AR (1) | AR072803A1 (es) |
AU (1) | AU2009272895A1 (es) |
BR (1) | BRPI0915862A2 (es) |
CA (1) | CA2730059A1 (es) |
CL (1) | CL2011000061A1 (es) |
IL (1) | IL209723A0 (es) |
MX (1) | MX2011000226A (es) |
PE (1) | PE20110207A1 (es) |
RU (1) | RU2541533C2 (es) |
TW (1) | TW201006802A (es) |
WO (1) | WO2010006940A1 (es) |
ZA (1) | ZA201009182B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
SG11201502527UA (en) * | 2012-10-05 | 2015-04-29 | Rigel Pharmaceuticals Inc | Gdf-8 inhibitors |
KR20160070162A (ko) * | 2013-11-05 | 2016-06-17 | 에프. 호프만-라 로슈 아게 | 자가면역 질병의 치료를 위한 RORc 조절인자로서 5,6,7,8-테트라하이드로-5,8-메타노신놀린 유도체 |
WO2016177686A1 (en) * | 2015-05-04 | 2016-11-10 | F. Hoffmann-La Roche Ag | PYRIDAZINE DERIVATIVES AS RORc MODULATORS |
CN107635971A (zh) * | 2015-05-04 | 2018-01-26 | 豪夫迈·罗氏有限公司 | 作为RORc调节剂的哒嗪衍生物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003022835A1 (en) * | 2001-09-06 | 2003-03-20 | Schering Corporation | 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
CA2474168A1 (en) * | 2002-02-01 | 2003-08-14 | Merck & Co., Inc. | 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
US7402580B2 (en) * | 2002-02-19 | 2008-07-22 | Ono Pharmaceutical Co., Ltd. | Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient |
DE60332862D1 (de) * | 2002-11-18 | 2010-07-15 | Schering Corp | 17beta-hydroxysteroid dehydrogenase typ-3 hemmer zur behandlung von androgen abhängigen erkrankungen |
RS51994B (en) * | 2005-07-05 | 2012-04-30 | F. Hoffmann-La Roche Ag | DERIVATI PIRIDAZINA |
BRPI0714200A2 (pt) * | 2006-07-05 | 2012-12-25 | Hoffmann La Roche | composto derivado de alquil-piridazina, processo para a sua preparaÇço, composiÇço farmacÊutica que compreende o mesmo, seu uso e mÉtodos para o tratamento e/ou profilaxia de enfermidades |
-
2009
- 2009-06-25 US US12/491,278 patent/US8501940B2/en not_active Expired - Fee Related
- 2009-07-06 CA CA2730059A patent/CA2730059A1/en not_active Abandoned
- 2009-07-06 EP EP09780161A patent/EP2313375A1/en not_active Withdrawn
- 2009-07-06 PE PE2011000019A patent/PE20110207A1/es not_active Application Discontinuation
- 2009-07-06 JP JP2011517854A patent/JP5575762B2/ja not_active Expired - Fee Related
- 2009-07-06 MX MX2011000226A patent/MX2011000226A/es active IP Right Grant
- 2009-07-06 WO PCT/EP2009/058470 patent/WO2010006940A1/en active Application Filing
- 2009-07-06 RU RU2011105058/04A patent/RU2541533C2/ru not_active IP Right Cessation
- 2009-07-06 AU AU2009272895A patent/AU2009272895A1/en not_active Abandoned
- 2009-07-06 BR BRPI0915862A patent/BRPI0915862A2/pt not_active IP Right Cessation
- 2009-07-06 CN CN2009801275297A patent/CN102089287B/zh not_active Expired - Fee Related
- 2009-07-06 KR KR1020117000916A patent/KR20110036579A/ko not_active Application Discontinuation
- 2009-07-13 TW TW098123640A patent/TW201006802A/zh unknown
- 2009-07-14 AR ARP090102663A patent/AR072803A1/es not_active Application Discontinuation
-
2010
- 2010-12-02 IL IL209723A patent/IL209723A0/en unknown
- 2010-12-21 ZA ZA2010/09182A patent/ZA201009182B/en unknown
-
2011
- 2011-01-11 CL CL2011000061A patent/CL2011000061A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN102089287A (zh) | 2011-06-08 |
AR072803A1 (es) | 2010-09-22 |
TW201006802A (en) | 2010-02-16 |
US20100016325A1 (en) | 2010-01-21 |
US8501940B2 (en) | 2013-08-06 |
PE20110207A1 (es) | 2011-03-31 |
WO2010006940A1 (en) | 2010-01-21 |
RU2541533C2 (ru) | 2015-02-20 |
JP5575762B2 (ja) | 2014-08-20 |
JP2011528003A (ja) | 2011-11-10 |
ZA201009182B (en) | 2011-10-26 |
KR20110036579A (ko) | 2011-04-07 |
RU2011105058A (ru) | 2012-08-20 |
CN102089287B (zh) | 2013-10-23 |
AU2009272895A1 (en) | 2010-01-21 |
BRPI0915862A2 (pt) | 2015-11-03 |
EP2313375A1 (en) | 2011-04-27 |
MX2011000226A (es) | 2011-02-24 |
CL2011000061A1 (es) | 2011-07-01 |
CA2730059A1 (en) | 2010-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201009182B (en) | Tetrahydrocinnolines as 11 beta hsd1 inhibitors for diabetes | |
ZA200902374B (en) | Compositions useful for the treatment of diabetes | |
ZA201006511B (en) | Heterocyclic compound | |
EP2345328A4 (en) | COMPOSITION FOR USE IN AGRICULTURE | |
EP2269990A4 (en) | HETEROCYCLIC COMPOUND | |
HK1139936A1 (en) | Substituted pyrimidodiazepines useful as plk1 inhibitors | |
ZA201007353B (en) | Herbicidal compositions comprising pyroxasulfone v | |
EP2181409A4 (en) | TEMPERATURE CENTER LUNGS OF OPERATIONS FACILITY-COMPENSATION | |
HK1161625A1 (en) | Screw | |
IL231955B (en) | Tetracycline compounds are substituted at the 7c position with fluorine | |
ZA201103738B (en) | Lactams as beta secretase inhibitors | |
EP2183425A4 (en) | STABILIZED DECOLORIZING COMPOSITION | |
HK1179514A1 (en) | Composition for external use | |
EP2295406A4 (en) | HETEROCYCLIC CONNECTION | |
HRP20150932T1 (en) | Heterocyclic compounds | |
ZA201007431B (en) | Imidazolidinone derivatives as 11b-hsd1 inhibitors | |
HK1147698A1 (en) | Composition for external application | |
EP2248420A4 (en) | HERBICIDE COMPOSITION | |
EP2287940A4 (en) | NITROGENIC HETEROCYCLIC COMPOUNDS CONTAINING COMPOSITION | |
HK1176155A1 (zh) | 響應時間補償 | |
GB0821011D0 (en) | Herbicidal composition | |
SI2176270T1 (sl) | Sestavki, ki vsebujejo spojine beta laktama | |
GB0718780D0 (en) | Hystereisi compensation scheme | |
EP2230240A4 (en) | STABLE CRYSTAL OF A B-LACTAM COMPOUND | |
PL2108852T3 (pl) | Śruba |